Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Optomed PLC (OPTOMED)

Helsinki
Currency in EUR
Disclaimer
4.10
-0.02(-0.36%)
Closed
OPTOMED Scorecard
Fair Value
Unlock Value
Day's Range
4.044.25
52 wk Range
2.314.67
Bid/Ask
4.06 / 4.06
Prev. Close
4.11
Open
4.25
Day's Range
4.04-4.25
52 wk Range
2.31-4.67
Volume
22,478
Average Volume (3m)
46,438
1-Year Change
5.1%
Shares Outstanding
17,776,424
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

People Also Watch

315.00
LIMET
-1.87%
2.75
BRETEC
-1.79%
60.00
TDVOX
-3.38%
How do you feel today about OPTOMED?
Vote to see community's results!
or

Optomed Company Profile

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, and Optomed Polaris brand names, as well as OEM cameras under the Pictor Plus and Pictor Prestige (Volk), Visuscout 100 (Zeiss), Fundus Module 300 (The Haag-Streit), and Signal (Topcon) brand names. The company provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a remote analysis solution; Avenue AI, a diabetic retinopathy screening service; Avenue Sync, a software for integrating fundus camera to the hospital image archive and worklist server; Avenue Flow, an eyecare management software; and Avenue SaaS, a software-as-a-service platform. In addition, it offers Cancer Screen, a screening process management software; Optomed RIS, a software solution for healthcare imaging units; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; and Pathology PACS, which allows digital pathology images to be reviewed and shared. It sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.

Employees
114
Market
Finland
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.